MINDCURE Announces Additional Equity Investment in ATMA, The First Government Approved Psychedelic Journey Centers In Canada; MCUR President and CEO, Kelsey Ramsden Named to ATMA Board of Directors
News provided by
Share this article
Share this article
ATMA Was The First Private Sector Service Provider In Canada Conducting Legal Psychedelic-Assisted Therapy For A Palliative Care Patient Under The Approval Of Health Canada s Section 56(1) Exemption
VANCOUVER, BC, April 8, 2021 /PRNewswire/ - Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) ( MINDCURE or the Company ) a leader in advanced proprietary technology for psychedelic therapy, is pleased to announce a further strategic equity investment in
ATMA Journey Centers Announces International Expansion to Costa Rica, Providing Clients a Range of Psychedelic Treatments Including Ayahuasca
newswire.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newswire.ca Daily Mail and Mail on Sunday newspapers.
Share:
Azul Journey Center will be guided by deeply experienced plant medicine elders of ancient cultural lineage who will assist in building the program s vision, operations and protocols
CALGARY, AB, March 8, 2021 /CNW/ -
ATMA Journey Centers Inc. (
ATMA ), an Alberta-based company focused on delivering innovative psychedelic-assisted therapies internationally, revealed plans today for the second private health and wellness Journey Center in its portfolio that focuses on the healing and transformative power of psychedelic medicine.
The company will own and operate Azul Journey Center on a picturesque ocean front property along the Nicoya Peninsula in Costa Rica, placing it within one of the world s five Blue Zones which refer to unique geographic areas where people have lower documented rates of chronic disease and live longer than anywhere else on the planet.
Mind Cure Signs LOI to Acquire an Ownership Interest in Psychedelic Treatment Center ATMA, Selected by Section 56 Exempt Patient for Psilocybin Therapy
News provided by
Share this article
Share this article
The strategic partnership between Mind Cure and ATMA will bridge access to research locations for psychedelic drug research while providing patient data for iSTRYM
, Mind Cure s digital therapeutics platform.
VANCOUVER, BC, Jan. 12, 2021 /PRNewswire/ - Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) ( Mind Cure or the
LOI ) for strategic investment and commercial cooperation with
ATMA Journey Centers Inc. (
ATMA ), a Calgary-based organization. ATMA is the first commercial treatment center in Canada to announce providing psychedelic-assisted therapy for a section 56 exempt patient. The LOI is intended to help Mind Cure secure an equity position within ATMA, empowering the Company with access to a global release strategy for
Reply
As the pandemic continues, organizers of New Trier LitFest thought it important to continue the uplifting tradition of New Trier s Literary Festival, an annual event which has inspired students and teachers alike since 2003. This year, LitFest happens in two parts: Part One took place on Monday, December 7, and Part Two is tentatively scheduled for April.
The day consisted of three 1-hour Zoom sessions, each hosted by a pair of artists. Each pair of artists created an inviting and energetic environment talking about writing, including their own work-its struggles and joys. They also used part of the time engaging students to write and share their own work.
vimarsana © 2020. All Rights Reserved.